It’s fitting that during the month of September, which is National Prostate Awareness month, British researchers have announced a new class of medications that shows promise for inhibiting prostate cancer growth.
According to Medical Daily, researchers from the Department of Pharmacy & Pharmacology and the Department of Chemistry at the University of Bath have zeroed in on a protein — called AMACR — that is highly active in aggressive prostate cancers, as well as in a number of other cancers.
The UK team developed new drugs that targeted and lowered the activity level of this aggressive protein. And this discovery may open up new pathways for research in treating a whole range of cancers, they say.
“This means that we have some really promising avenues to explore as we work toward developing new treatments against prostate cancer and other cancers where AMACR is involved,” says Dr. Matthew Lloyd, lead author from the Department of Pharmacy & Pharmacology.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
4 comments:
If my comment is posted you will save many lives.First of all no sex causes prostate cancer,but most importantly,Viagra cures prostate cancer 100%.Never ever has anyone who has taken Viagra contracted prostate cancer.Never.
Could, May, Might . . .
All words used by liars!
Do you drink in excess ?
Agreed 8:45
Post a Comment